Literature DB >> 11897517

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Marc Estenne1, Janet R Maurer, Annette Boehler, James J Egan, Adaani Frost, Marshall Hertz, George B Mallory, Gregory I Snell, Samuel Yousem.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11897517     DOI： 10.1016/s1053-2498(02)00398-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  273 in total

1.  Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation.

Authors:  Dianhua Jiang; Jiurong Liang; Rishu Guo; Ting Xie; Francine L Kelly; Tereza Martinu; Ting Yang; Alysia K Lovgren; Jessica Chia; Ningshan Liu; Yoosun Jung; Scott M Palmer; Paul W Noble
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-08       Impact factor: 6.914

2.  Lung function early after lung transplantation is correlated with the frequency of regulatory T cells.

Authors:  Tomoyuki Nakagiri; Gregor Warnecke; Murat Avsar; Stefanie Thissen; Bianca Kruse; Christian Kühn; Petra Ziehme; Ann-Kathrin Knöfel; Nodir Madrahimov; Meinoshin Okumura; Yoshiki Sawa; Jens Gottlieb; André R Simon; Axel Haverich; Martin Strüber
Journal:  Surg Today       Date:  2011-12-17       Impact factor: 2.549

3.  Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

Authors:  Xue Lin; Wenjun Li; Jiaming Lai; Mikio Okazaki; Seiichiro Sugimoto; Sumiharu Yamamoto; Xingan Wang; Andrew E Gelman; Daniel Kreisel; Alexander Sasha Krupnick
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

4.  Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.

Authors:  C Ashley Finlen Copeland; Laurie D Snyder; David W Zaas; W Jackson Turbyfill; W Austin Davis; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

5.  Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.

Authors:  Jamie L Todd; Rahil Jain; Elizabeth N Pavlisko; C Ashley Finlen Copeland; John M Reynolds; Laurie D Snyder; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

6.  Long-Term Follow-up of a Randomized Controlled Trial Evaluating a Mobile Health Intervention for Self-Management in Lung Transplant Recipients.

Authors:  E M Rosenberger; A J DeVito Dabbs; A F DiMartini; D P Landsittel; J M Pilewski; M A Dew
Journal:  Am J Transplant       Date:  2016-10-31       Impact factor: 8.086

7.  A new murine model for bronchiolitis obliterans post-bone marrow transplant.

Authors:  Angela Panoskaltsis-Mortari; Kevin V Tram; Andrew P Price; Christine H Wendt; Bruce R Blazar
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

8.  Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients.

Authors:  Laurie D Snyder; Ziwei Wang; Dong-Feng Chen; Nancy L Reinsmoen; C Ashley Finlen-Copeland; W Austin Davis; David W Zaas; Scott M Palmer
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

9.  Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.

Authors:  Aric L Gregson; Xiaoyan Wang; S Sam Weigt; Vyacheslav Palchevskiy; Joseph P Lynch; David J Ross; Bernard M Kubak; Rajan Saggar; Michael C Fishbein; Abbas Ardehali; Gang Li; Robert Elashoff; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

Review 10.  Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation.

Authors:  Ramsey Hachem; Paul Corris
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.